To study the Yogvahi action of Rasasindoor with Eclipta alba(Bhringraj) in management of essential B.P.
Not Applicable
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2022/02/040309
- Lead Sponsor
- SHRI KRISHNA AYUSH UNIVERSITY KURUKSHETRA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients who already diagnosed as E.H.T will be selected.
2.Patients with Stage 1 Hypertension(having systolic B.P. upto 160 and diastolic B.P. upto 100 )will be selected for the study.
3.Patients willing to give written inform consent to participate in the study
Exclusion Criteria
1.Essential hypertension with any complications.
Renal diseases, Diabetic mellitus
2.Pregnancy induced hypertension.
3.Patients using drugs like oral contraceptive pills, steroids.
4.Ventricular hypertrophy, secondary hypertension, coarctation of aorta.
Portal hypertension
5.Renal artery stenosis induced hypertension
6.Patients who enroll in some other clinical trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To rule out the significant result of Rasasindoor with Aqueous extract of Eclipta alba in management of Essential Hypertension.Timepoint: 4 Weeks
- Secondary Outcome Measures
Name Time Method Change in lab parametrs from baseline.Timepoint: 4 weeks